Vaccines for COVID-19 in India have been allowed to be administered among large pool of adult population. In-depth knowledge regarding the adverse effect of vaccine is scarce till date, mainly due to the lack of reporting, analysing and making the data publicly available. Informed choice by the recipients is totally barred and further, compensation associated with the vaccination is also compromised. These important issues need to be highlighted in the public forum for greater awareness and action.
ArshadiA. K., WebbJ., SalemM., CruzE., Calad-ThomsonS., GhadirianN., CollinsJ., Diez-CeciliaE., KellyB., GoodarziH., & YuanJ. S. (2020). Artificial intelligence for COVID-19 drug discovery and vaccine development. Frontiers in Artificial Intelligence, 3(65), 1–13.
2.
BanerjiA., WicknerP. G., SaffR., StoneC. A., RobinsonL. B., LongA. A., WolfsonA. R., WilliamsP., KhanD. A., PhillipsE., & BlumenthalK. G. (2021). mRNA vaccines to prevent COVID-19 diseases and reported allergic reactions: Current evidence and suggested approach. Journal of Allergy and Clinical Immunology: In Practice, 9(4), 1423–1437. https://doi.org/10.1016/j.jaip.2020.12.047
3.
BhatiaM., PutchaV., DwivediL. K., & SinghD. P. (2021). Serious adverse events and fatal outcomes following COVID-19 vaccination in the UK: Lessons for other countries. The International Journals of Community and Social Development, 3(4).
4.
DW. (2021, March 15). Fact check. No links found between vaccination deaths. Retrieved March 15, 2021, fromhttps://www.dw.com/en/fact-check-no-links-found-between-vaccination-and-deaths/a-56458746
5.
GeeJ., MarquezP., SuJ., CalvertG. M., LiuR., MyersT., NairN., MartinS., ClarkT., MarkowitzL., LindseyN., ZhangB., LicataC., JazwaA., SotirM., & ShimabukuroT. (2021). First month of COVID-19 vaccine safety monitoring- United States, December 14, 2020–January 13, 2021. MMWR. Morbidity and Mortality Weekly Report, 70(8), 283–288. https://doi.org/10.15585/mmwr.mm7008e3
6.
MeherB. K. (2019). Vaccine pharmacovigilance in India: Current context and future perspective. Indian Journal of Pharmacology, 51(4), 1–9.
7.
MeskoB. (2017). The role of artificial intelligence in precision medicine. Expert Review of Precision Medicine and Drug Development, 2(5), 239–241. https://doi.org/10.1080/23808993.2017.1380516
8.
Medicines and Healthcare Products Regulatory Agency. (2021). Coronavirus vaccine—Weekly summary of Yellow Card reporting [Published online first]. Retrieved March 20, 2021, from https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting#yellow-card-reports
9.
MulchandaniR., & KakkarA. K. (2018). Reporting of adverse drug reactions in India: A review of the current scenario. International Journal of Risk and Safety in Medicine, 30(1), 1–12.
10.
The Hindu. (2021, April 9). Coronavirus: 180 deaths following vaccination reported in India. Chennai, India. Retrieved April 9, 2021, from https://www.thehindu.com/news/national/coronavirus-180-deaths-following-vaccination-reported-in-india/article34274144.ece
11.
VoyseyM., ClemensS. A. C., MadhiS. A., WeckxL. Y., FolegattiP. M., AleyP. K., AngusB., BaillieV. L., BarnabasS. L., BhoratQ. E., BibiS., BrinerC., CicconiP., CollinsA. M., Colin-JonesR., CutlandC. L., DartonT. C., DhedaK., DuncanC. J. A., & Group.… Oxford COVID Vaccine Trial (2021). Safety and efficacy of the ChAdOx1 nCov-19 vaccine (AZD1222) against SARS-Cov-2: An interim analysis of four randomized controlled trials in Brazil, South Africa, and the UK. Lancet, 397(10269), 99–111. https://doi.org/10.1016/S0140-6736(20)32661-1
12.
WHO. (2021). No-fault compensation programme for COVID-19 vaccine is a world first. Retrieved February 22, 2021, from https://www.who.int/news/item/22-02-2021-no-fault-compensation-programme-for-covid-19-vaccines-is-a-world-first
